Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Encompass Health Corp is a medical care facilities business based in the US. Encompass Health shares (EHC) are listed on the NYSE and all prices are listed in US Dollars. Encompass Health employs 34,000 staff and has a trailing 12-month revenue of around $5.3 billion.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $47.72 |
|---|---|
| 52-week range | $41.92 - $61.18 |
| 50-day moving average | $50.67 |
| 200-day moving average | $51.21 |
| Wall St. target price | $65.42 |
| PE ratio | 15.5688 |
| Dividend yield | $1.12 (1.18%) |
| Earnings per share (TTM) | $3.27 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $47.72 from 2022-09-23
| 1 week (2022-09-19) | -7.01% |
|---|---|
| 1 month (2022-08-26) | -2.47% |
| 3 months (2022-06-24) | -16.85% |
| 6 months (2022-03-25) | -29.72% |
| 1 year (2021-09-24) | -38.03% |
|---|---|
| 2 years (2020-09-25) | -23.75% |
| 3 years (2019-09-26) | 62.09 |
| 5 years (2017-09-25) | 6.52% |
Valuing Encompass Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Encompass Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Encompass Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Encompass Health shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Encompass Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $991.5 million.
The EBITDA is a measure of a Encompass Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $5.3 billion |
|---|---|
| Operating margin TTM | 13.78% |
| Gross profit TTM | $2 billion |
| Return on assets TTM | 6.63% |
| Return on equity TTM | 17.83% |
| Profit margin | 6.22% |
| Book value | $20.07 |
| Market capitalisation | $5.1 billion |
TTM: trailing 12 months
Dividend payout ratio: 24.55% of net profits
Recently Encompass Health has paid out, on average, around 24.55% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.18% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Encompass Health shareholders could enjoy a 1.18% return on their shares, in the form of dividend payments. In Encompass Health's case, that would currently equate to about $1.12 per share.
While Encompass Health's payout ratio might seem low, this can signify that Encompass Health is investing more in its future growth.
Encompass Health's most recent dividend payout was on 16 October 2022. The latest dividend was paid out to all shareholders who bought their shares by 29 September 2022 (the "ex-dividend date").
Encompass Health's shares were split on a 1257:1000 basis on 30 June 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1257 shares. This wouldn't directly have changed the overall worth of your Encompass Health shares – just the quantity. However, indirectly, the new 20.4% lower share price could have impacted the market appetite for Encompass Health shares which in turn could have impacted Encompass Health's share price.
Over the last 12 months, Encompass Health's shares have ranged in value from as little as $41.9236 up to $61.1754. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Encompass Health's is 0.9113. This would suggest that Encompass Health's shares are less volatile than average (for this exchange).
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.